Pachyonychia Congenita
📧 Sign up to get email alerts when something new happens for Pachyonychia Congenita.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Epidermal Growth Factor Receptor Inhibition for Keratinopathies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating epidermal growth factor receptor inhibition for keratinopathy diseases, including Epidermolytic ichthyos…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC [Phase 1]
This update reports the completion of a Phase 1 study evaluating KM-001 for safety, tolerability, and potential efficacy in patients with Pu…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases [Phase 1]
A Phase 1 trial update notes completion of a study evaluating the safety and potential efficacy of a 1% topical KM-001 formulation for Punct…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita [Phase 3]
A multicenter Phase 3 randomized, double-blind, vehicle-controlled trial evaluating QTORIN 3.9% Rapamycin Anhydrous Gel for Pachyonychia Con…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita [Phase 3]
Phase 3 study evaluating PTX022 for Pachyonychia Congenita has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita [Phase 2, Phase 3]
This clinical trial update reports that Palvella Therapeutics' PTX-022 Phase 2/3 study for Pachyonychia Congenita has completed. The update …
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita [Phase 3]
A Phase 3 clinical trial evaluating the safety and pharmacokinetics of QTORIN Rapamycin 3.9% anhydrous gel for pachyonychia congenita is cur…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin [Phase 1]
A Phase 1 trial funded by Johns Hopkins University evaluating whether broccoli sprout extract affects keratinocyte differentiation in normal…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC) [Phase 1]
This Phase 1 trial evaluated topical sirolimus for pachyonychia congenita. The study is completed and results were posted in 2016.
-
CLINICAL_TRIALS research · 2011-06-27Clinical Trial Update: Simvastatin Treatment of Pachyonychia Congenita [NA]
A clinical trial update indicates a study evaluating simvastatin for Pachyonychia Congenita, sponsored by Tel-Aviv Sourasky Medical Center, …
-
CLINICAL_TRIALS research · 2011-03-09Clinical Trial Update: Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita [Phase 2]
Phase 2 clinical trial update on Botulinumtoxin A for Epidermolysis Bullosa Simplex and Pachyonychia Congenita; sponsor is Uppsala Universit…
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita [Phase 1]
Phase 1 clinical trial of TD101, an siRNA therapy, for Pachyonychia Congenita has been completed.